HOME >> BIOLOGY >> NEWS
Stem-cell research and reproductive cloning laws should be separate

The author of a Public Policy article in this week's issue of THE LANCET discusses recent failures of international organisations to establish clear policies with regard to stem-cell research and reproductive cloning. This will have implications for research scientists who will not be clear about the type of research programmes that could be publicly funded or that are legally permissible in the near future.

Carol A Tauer (Center for Bioethics, University of Minnesota, USA) outlines how late last year two international bodies were unable to resolve disagreements that involved bioethical issues. First, the United Nations General Assembly failed to pass a treaty on reproductive cloning because of insistence by some countries that the treaty include a ban on cloning for research. She argues that in view of the importance of enacting prohibition of reproductive cloning, the two issues should be separated and each argued on its own merits. Second, Dr Tauer discusses how the European Union (EU) failed to agree on conditions for funding stem-cell research because of the diversity of views and policies of the countries of the EU. Because a stalemate was reached, funding decisions in the next programme cycle will be made on an ad hoc basis.

Dr Tauer comments: "A country or group of countries can legitimately not fund certain controversial types of scientific or biomedical research. But a decision is preferable to a stalemate. Scientists who do not know what types of research proposals can be considered for funding are likely to shy away from a particular area of investigation. In this respect, the US rules, while restrictive, might have some advantages over the EU's lack of agreement on rules. If clear rules exist about what can and cannot be publicly funded then scientists can plan and seek private funding if necessary. The EU needs to break its stalemate and agree on funding policies, if not within the Sixth Framework Programme then at least by the time o
'"/>

Contact: Joe Santangelo
j.santangelo@elsevier.com
212-633-3810
Lancet
8-Jul-2004


Page: 1 2

Related biology news :

1. Stem-cell therapy could have benefits and risks for heart-attack PTs
2. Stem-cell defect underlies common genetic disorder
3. Leader in cancer treatment and prevention research honored
4. UT Southwestern receives $1.78 million grant for obesity research as part of NIH Roadmap initiative
5. Scientists to prototype cyberinfrastructure for research and education access to ocean observatories
6. Belgian researchers explore revolutionary approach to angiogenesis
7. Award winning researchers reveal potential new role for Glivec
8. New research shows plants can shuffle and paste gene pieces to generate genetic diversity
9. 16 APS exercise research highlights, from reduced flu mortality to proteomics & obesity
10. Gene chips research in cotton could lead to superior variety
11. Groundbreaking research could ignite new solutions to heat transfer in nano-devices

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/14/2019)... Calif. (PRWEB) , ... January 14, 2019 , ... ... proprietary technology to detect precancer and cancer cells in blood, will present new ... significant advancement in the fight against colorectal cancer. The results from this study ...
(Date:1/10/2019)... ... January 10, 2019 , ... A major goal ... in vitro studies and significantly more expensive in vivo studies in order to ... To address this need, researchers have begun to adopt 3D cell culture models ...
(Date:1/7/2019)... , ... January 07, 2019 , ... ... and Artificial Intelligence solutions for precision health in oncology and other key therapeutic ... Morgan’s exclusive meeting of investors, entrepreneurs and executives spanning the entire healthcare landscape, ...
Breaking Biology News(10 mins):
(Date:1/30/2019)... China and SAN DIEGO (PRWEB) , ... January ... ... leading and fully integrated Contract Development and Manufacturing Organization (CDMO) serving the global ... closed its series A funding of $59.1 million backed by multiple global investors ...
(Date:1/30/2019)... (PRWEB) , ... January 30, 2019 , ... ... experts from pharma, academia and governmental agencies to discuss best practices for laboratory ... from February 4-6. , At this year’s conference, Visikol will be at ...
(Date:1/24/2019)... ... January 22, 2019 , ... Dr. Douglas Stramel of ... Veterinary Platelet Enhancement Therapy System (V-PET™) for nearly three years. A proponent ... Therapy since 2007 and began using V-PET™ 2016. V-PET™ is a gravity ...
(Date:1/20/2019)... ... January 17, 2019 , ... Consumers are directing healthcare in ... physicians. That's changing as many services now exist for patients to order tests ... totaled $208 million in 2018, according to Kalorama Information’s new report, The ...
Breaking Biology Technology:
Cached News: